Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for reducing side effects from administration of phosphodiesterase-4 inhibitors

Method for reducing side effects from administration of phosphodiesterase-4 inhibitors

US Patent 12390453 · Granted Aug 19, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical compositions of spironolactone for deep dermal drug delivery2025
Topical roflumilast aerosol foams2025
Inhibition of crystal growth of roflumilast2025
Topical roflumilast formulation having antifungal properties2025
Topical roflumilast formulation having improved delivery and plasma half-life2025
Inhibition of crystal growth of roflumilast2025
Roflumilast formulations with an improved pharmacokinetic profile2025
Pharmaceutical compositions of roflumilast and solvents capable of dissolving hi2024
Laureth-4 containing topical formulations2024
Compositions and methods for deep dermal drug delivery2024
Method for reducing side effects from administration of phosphodiesterase-4 inhi2024
Method and formulation for improving roflumilast skin penetration lag time2024